FSD PHARMA RECEIVES FIRST DELIVERY OF CANTABB EQUIPMENT WITH A CAPACITY TO MANUFACTURE APPROX. 1,500,000 TABLETS PER DAY
TORONTO, Sept. 25, 2018 /PRNewswire/ -
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) ("
FSD Pharma" or the "
Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the
Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab Therapeutics Limited (CSE
ILL) ("
Canntab"), a leader in the rapidly growing cannabis pill market.
The manufacturing equipment consists of a fully GMP High output Tablet press capable of pressing more than 1,500,000 tablets per day, as well as blending machinery, large scale process and drying equipment and packaging equipment.
Mr. Jeffrey Renwick, Chief Executive Officer of Canntab, stated, "With this first delivery of manufacturing equipment at the Cobourg plant, we can begin the process of setting up our manufacturing space in collaboration with FSD Pharma. We expect manufacturing of our suite of novel cannabis oral dose delivery platforms, including gel capsules and tablets to begin in earnest."
I will wait until I hear from Canntab. Please refer to my post where I clearly add further clarification: Post #:
64659406